MRN Announces Distribution Agreement Between MRN and Biomex GMBH

Medical Research Networx, LLC (MRN) announced today a Distribution Agreement between MRN and Biomex GMBH of Heidelberg, Germany, making MRN the exclusive distributor of Biomex products in the United States.  Biomex is a worldwide provider of human plasma for further manufacture of IVD products, offering high volume plasma from patients with infectious diseases such as plasma containing high titers of IgM antibodies to toxoplasma, rubella, cytomegalovirus and herpes simplex virus (ToRCH Panel).  Biomex also provides high volume plasma with high antibody titers to HIV g O, HIV 2, Hepatitis B Surface Antigen (HBsAg) Ad/Ay, most HCV genotypes, allergens, Dengue virus, Tick-borne encephalitis (TBE/FSME), Borrelia burgdorferi (Lyme disease) and many more.  The Biomex offering provides seroconversion, performance and other panels, and is complimented by MRN's Global Network of clinical investigators offering a comprehensive resource of well-annotated biospecimens to IVD Manufacturers.

Robert O. McKie, President and CEO of MRN, noted that “Biomex provides complimentary products and services for our IVD Customers in the United States, providing critical raw materials for manufacturing controls and calibrators used in numerous IVD Test Kits.”

© 2018 Medical Research Networx